QuBEST BIO is a nonclinical and preclinical CRO that has provided experienced and high performance services to the South Korean biotech industry since 2008 and is now also opening its services to the global market.
Bioanalysis Capabilities:
- Rapid Discovery Screen – Rapid Screening for Hit-to-Lead
- Lead Optimization (Non-GLP Early PK Studies) – PK for Candidate Selection
- Lead Qualification (Non-GLP TK Studies) – Systemic Exposure from DRF
- Method Development, Validation and Sample Analysis (various matices)
- Small molecules + metabolites, peptides, ADC free payload, etc.
- GLP Bioanalysis (by 3Q 2025)
In Vivo Pharmacokinetic Studies (non-radiolabeled):
- Species: all laboratory species including NHPs
- Bioequivalence / Bioavailability assessments
- Gender difference / Food effects
- Parameter calculation using R packages for noncompartmental analysis
- Dose, bleed & ship
- Excel data sheet / full report
Facilities and Instrumentation:
- Dedicated laboratory spaces – PK animal room
- 8 Triple Quadrupole Mass Spectrometers – AB Sciex 6500+ (2), 5500+ (3), and 4500 (3) w/ UHPLC systems
Extensive Bioanalysis Experience for Popular API:
Semaglutide, Rivastigmine, Donepezil, Leuprolide, Dexamethasone, Entecavir, Finasteride, Ropivacaine, Exenatide, Tirzepatide, Nicotinamide adenine dinucleotide(NAD), Pamoic acid, Phenacetin, Tolbutamide, Bupropion, Amodiaquine, S-Mephenytoin, Dextromethorphan, Midazolam, Metformin, Furosemide, Niclosamide, Testosterone, Goserelin, Dutasteride, Diclofenac, Clozapine, Desipramin
As part of a rapidly-expanding and highly-specialized South Korean biotech industry, we believe in doing our work with the utmost efficiency at the highest standard while also providing cost-effective services.
And as a team with high levels of knowledge, experience, skills, project management know-how, networking, collaborative efforts, and most of all, passion, let us show you how we can help reach your drug development pipeline goals.
Company Details
- Employees
- 6
- Founded
- -
- Address
- Daewoo Frontier Valley,16-25, Dongbaekjungang-Ro 16beon-Gil, Giheung-Gu,
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- http://www.qubest.co.kr/
- Keywords
- PK/TK services, Toxicology services, Pharmacology services, Bioanalysis services, Preclinical CRO, Nonclinical CRO, Drug Development Consulting services, GLP & Non-GLP Toxicology.
- HQ
- Yongin-si, Gyeonggi-do
Qubest Bio Questions
Qubest Bio's website is http://www.qubest.co.kr/
Qubest Bio's LinkedIn profile is https://www.linkedin.com/company/qubest
Qubest Bio has
6 employees.
View email and phone details for 6
employees at Qubest Bio.
Qubest Bio's industry is
Biotechnology Research
Qubest Bio's top competitors are
Kcrn Research,
Atlas Biotechnologies,
Autotelic Bio Inc.,
Kcas Bio,
Mps Limited,
Be Biopharma,
The Clinical Research Coordinator Academy (The Crc Academy),
Mplusheal Biotech,
Salura Health,
Higher Medicine.
Qubest Bio's categories are Biotechnology Research
Qubest Bio's founding year is 2008
